References
- Barry V, Belton JG, Conalty MLet al.A new series of phenazines (rimino-compounds) with high antituberculosis activity. Nature 1957;179: 1013–1015.
- Cholo MC, Steel HC, Fourie PBet al.Clofazimine: current status and future prospects. J Antimicrob Chemother 2012;67: 290–298.
- Van Deun A, Maug AK, Salim MAet al.Short, highly effective and inexpensive standardized treatment of multidrug-resistant tuberculosis. Am J Respir Crit Care Med 2010;182: 684–692.
- Hartkoorn RC, Uplekar S, Cole ST.Cross-resistance between clofazimine and bedaquiline through upregulation of MmpL5 in Mycobacterium tuberculosis. Antimicrob Agents Chemother 2014;58: 2979–2981.
- Zhang S, Chen J, Cui Pet al.Identification of novel mutations associated with clofazimine resistance in Mycobacterium tuberculosis. J Antimicrob Chemother 2015;70: 2507–2510.
- Van Rensburg CE, Joone GK, O'Sullivan JFet al.Antimicrobial activities of clofazimine and B669 are mediated by lysophospholipids. Antimicrob Agents Chemother 1992;36: 2729–2735.
- Yano T, Kassovska-Bratinova S, Teh JSet al.Reduction of clofazimine by mycobacterial type 2 NADH:quinone oxidoreductase: a pathway for the generation of bactericidal levels of reactive oxygen species. J Biol Chem 2011;286: 10276–10287.
- Ammerman NC, Swanson RV, Tapley Aet al.Clofazimine has delayed antimicrobial activity against Mycobacterium tuberculosis both in vitro and in vivo. J Antimicrob Chemother 2016;72: 455–461.
- Tyagi S, Ammerman NC, Li SYet al.Clofazimine shortens the duration of the first-line treatment regimen for experimental chemotherapy of tuberculosis. Proc Natl Acad Sci USA 2015;112: 869–874.
- Zhang Y, Shi W, Zhang Wet al.Mechanisms of pyrazinamide action and resistance. Microbiol Spectr 2013;2: 1–12.
- Zhang S, Chen J, Shi Wet al.Mutations in panD encoding aspartate decarboxylase are associated with pyrazinamide resistance in Mycobacterium tuberculosis. Emerg Microbes Infect 2013;2: e34.
- Ferro BE, Meletiadis J, Wattenberg Met al.Clofazimine prevents the regrowth of Mycobacterium abscessus and Mycobacterium avium type strains exposed to amikacin and clarithromycin. Antimicrob Agents Chemother 2016;60: 1097–1105.
- Oliva B, O'Neill AJ, Miller Ket al.Anti-staphylococcal activity and mode of action of clofazimine. J Antimicrob Chemother 2004;53: 435–440.
- Zhang Y, Wade MM, Scorpio Aet al.Mode of action of pyrazinamide: disruption of Mycobacterium tuberculosis membrane transport and energetics by pyrazinoic acid. J Antimicrob Chemother 2003;52: 790–795.
- Hurdle JG, O'Neill AJ, Chopra Iet al.Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections. Nat Rev Microbiol 2011;9: 62–75.